The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    CYNORA Secures $25M, Appoints Kablanian as CEO

    Article obtained from Photonics RSS Feed.

    CYNORA GmbH has secured $25 million in financing from the U.S., Germany, and Korea to produce ultrahigh-efficiency emitter systems required for next-generation organic light-emitting diode displays.

    The Germany-based company has raised $80 million since its inception in 2008. The funds will be used to build an infrastructure to support the production and sales of CYNORA’s thermally activated delayed fluorescence materials for next-generation OLED displays.

    Included in the agreement is the appointment of Adam Kablanian as chief executive officer. He succeeds Gildas Sorin, who led the company through research and development and early customer engagements. Sorin will remain at CYNORA during the transition.

    Kablanian previously led several Silicon Valley-based public and privately held companies. They include Virage Logic, which he co-founded, and PlasmaSi, an OLED encapsulation company. A multitime technology company CEO, Kablanian will lead CYNORA from the company’s headquaters in Germany.

    Kablanian holds a B.A. in physics from the University of California, Berkeley, and an M.S. in electrical engineering from Santa Clara University.

    May, 15 2019 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.